The neurofilament light chain protein (NFL) is an inflammatory cytokine and has been reported to be the first blood biomarker that could be used to predict the progression rate of ALS and stratify patients based on their expected survival times [73,91]. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.